Below are the most recent publications written about "Mesenchymal Stem Cell Transplantation" by people in Profiles.
-
Gomez-Galvez Y, Gupta M, Kaur M, Fusco S, Podda MV, Grassi C, Srivastava AK, Iacovitti L, Blanco-Suarez E. Recovery after human bone marrow mesenchymal stem cells (hBM-MSCs)-derived extracellular vesicles (EVs) treatment in post-MCAO rats requires repeated handling. PLoS One. 2024; 19(10):e0312298.
-
Fares MY, Shehade TH, Daher M, Boufadel P, Koa J, Abboud JA. Mesenchymal Stem Cell Injections for the Treatment of Osteoarthritis: A Systematic Review of Clinical Trials. Acta Orthop Belg. 2024 Jun; 90(2):319-333.
-
Arceri A, Mazzotti A, Artioli E, Zielli SO, Barile F, Manzetti M, Viroli G, Ruffilli A, Faldini C. Adipose-derived stem cells applied to ankle pathologies: a systematic review. Musculoskelet Surg. 2024 Mar; 108(1):1-9.
-
Myers MI, Hines KJ, Gray A, Spagnuolo G, Rosenwasser R, Iacovitti L. Intracerebral Transplantation of Autologous Mesenchymal Stem Cells Improves Functional Recovery in a Rat Model of Chronic Ischemic Stroke. Transl Stroke Res. 2025 Apr; 16(2):248-261.
-
DI Martino A, Barile F, Fiore M, Ruffilli A, Faldini C. Are injectable regenerative therapies effective in the treatment of degenerative disc disease? A systematic review. J Neurosurg Sci. 2022 Oct; 66(5):399-405.
-
Aligholi H, Safahani M, Asadi-Pooya AA. Stem cell therapy in patients with epilepsy: A systematic review. Clin Neurol Neurosurg. 2021 01; 200:106416.
-
Choudhery MS, Harris DT. Stem cell therapy for COVID-19: Possibilities and challenges. Cell Biol Int. 2020 Nov; 44(11):2182-2191.
-
Garza JR, Campbell RE, Tjoumakaris FP, Freedman KB, Miller LS, Santa Maria D, Tucker BS. Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial. Am J Sports Med. 2020 03; 48(3):588-598.
-
Yan W, Lin C, Guo Y, Chen Y, Du Y, Lau WB, Xia Y, Zhang F, Su R, Gao E, Wang Y, Li C, Liu R, Ma XL, Tao L. N-Cadherin Overexpression Mobilizes the Protective Effects of Mesenchymal Stromal Cells Against Ischemic Heart Injury Through a ?-Catenin-Dependent Manner. Circ Res. 2020 03 27; 126(7):857-874.
-
Rashidghamat E, Kadiyirire T, Ayis S, Petrof G, Liu L, Pullabhatla V, Ainali C, Guy A, Aristodemou S, McMillan JR, Ozoemena L, Mee J, Pramanik R, Saxena A, Nuamah R, de Rinaldis E, Serrano S, Maurin C, Martinez-Queipo M, Lwin SM, Ilic D, Martinez A, Dazzi F, Slaper-Cortenbach I, Westinga K, Zeddies S, van den Broek M, Onoufriadis A, Mellerio JE, McGrath JA. Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 2020 Aug; 83(2):447-454.